CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 4 Open-market sale Chief Scientific Officer sold 128,257 shares at $4.25 ($545,092)
- 4 Shares withheld for taxes President and CEO gave up 15,732 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 27,885 shares (to pay taxes)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4/A Insider Changes in Ownership
- 4 Open-market buy President and CEO bought 10,000 shares at $3.24 ($32,446)
- 4 Open-market sale Chief Scientific Officer sold 63,479 shares at $3.48 ($221,199)
- 4 Shares withheld for taxes President and CEO gave up 15,732 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 27,885 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 15,732 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 307,911 shares at an average $4.00 ($1,230,933)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 20 of 31 · 620 filings